4 completed, 2 unknown, 1 suspended, 1 withdrawn. 2 Not applicable, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 2 | Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Graft Loss: new trials by email Literature Review of Graft Loss trials Research Report on Graft Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection Antibody-mediated Rejection, Kidney Transplant Rejection | Completed | Istanbul University | 75 | 2019-09-01 | 2021-05-18 | |
| Recipient Site Pre-conditioning in Fat Grafting pre-expansion using Kiwi® VAC-6000M., pre-heating using Hilotherm Calido®., pre-expansion-heating - Graft Loss, Condition | Not applicable | Completed | University Hospital, Basel, Switzerland | 60 | 2018-01-08 | 2025-03-12 |
| The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction N-Acetylcysteine (NAC) - Breast; Deformity, Congenital, Graft Loss | Phase 4 | Unknown | Centre of Postgraduate Medical Education | 15 | 2017-07-04 | 2017-07-06 |
| Effect of N-Acetylcysteine on Autologous Fat Graft Survival Acetylcysteine - Adipose Tissue Atrophy, Deformity of Reconstructed Breast | Phase 4 | Withdrawn | Nova Scotia Health Authority | 2016-08-15 | 2024-08-21 | |
| Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients mesenchymal stromal cells - Rejection, Graft Loss | Phase 1 | Completed | Leiden University Medical Center | 10 | 2015-03-01 | 2019-07-02 |
| Factors Influencing Bone Block Allograft Resorption graft surgery - Graft Loss | Not applicable | Completed | Universidad Complutense de Madrid | 28 | 2011-01-01 | 2018-01-26 |
| Graft Take and Microbiology in Burns Transplantation Infection, Wound of Skin | Suspended | Federal University of São Paulo | 30 | 2010-10-01 | 2012-01-10 | |
| Long-term Outcomes After Conversion to Belatacept Conversion to a belatacept regimen - Kidney Transplant Failure and Rejection, Immunosuppression | Unknown | Paris Translational Research Center for Organ Transplantation | 324 | 2004-01-01 | 2021-02-01 |
Rejection, Psychology (2) · Atrophy (1) · Burns (1) · Congenital Abnormalities (1) · Disease (1) · Infections (1)
Behavior (2) · Pathological Conditions, Signs and Symptoms (2) · Social Behavior (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Wounds and Injuries (1)
Acetylcysteine (2) · Abatacept (1)
Centre of Postgraduate Medical Education (1) · Federal University of São Paulo (1) · Istanbul University (1) · Leiden University Medical Center (1) · Nova Scotia Health Authority (1) · Paris Translational Research Center for Organ Transplantation (1) · Universidad Complutense de Madrid (1) · University Hospital, Basel, Switzerland (1)
Netherlands (1) · Poland (1) · Switzerland (1) · Turkey (Türkiye) (1)
Alexandre Loupy, MD, PhD (1) · Dirk J Schaefer, Prof MD (1) · Halil Yazici, MD (1) · Jesus Torres (1) · Marlies EJ Reinders, MD/PhD (1) · Piotr Pietruski, M.D. (1) · Safak Mirioglu, MD (1)
PMID 26537851, PMID 32221675, PMID 32424535, PMID 38265815, PMID 41389580